Propel Bio Management, LLC Compass Therapeutics, Inc. Transaction History
Propel Bio Management, LLC
- $86.1 Billion
- Q1 2025
A detailed history of Propel Bio Management, LLC transactions in Compass Therapeutics, Inc. stock. As of the latest transaction made, Propel Bio Management, LLC holds 228,317 shares of CMPX stock, worth $662,119. This represents 0.5% of its overall portfolio holdings.
Number of Shares
228,317Holding current value
$662,119% of portfolio
0.5%Shares
1 transactions
Others Institutions Holding CMPX
# of Institutions
121Shares Held
101MCall Options Held
2.52MPut Options Held
3.1M-
Orbimed Advisors LLC San Diego, CA22.4MShares$64.9 Million1.32% of portfolio
-
Tang Capital Management LLC San Diego, CA11.1MShares$32.1 Million1.36% of portfolio
-
Blackstone Inc New York, NY10MShares$29.1 Million0.09% of portfolio
-
Bio Impact Capital LLC Cambridge, MA8.44MShares$24.5 Million2.97% of portfolio
-
Black Rock Inc. New York, NY6.61MShares$19.2 Million0.0% of portfolio
About Compass Therapeutics, Inc.
- Ticker CMPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 101,285,000
- Market Cap $294M
- Description
- Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...